Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
42.1M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
8.05M
-
Shares change
-
+7.96M
-
Total reported value, excl. options
-
$20.2M
-
Value change
-
+$20M
-
Number of buys
-
12
-
Number of sells
-
-3
-
Price
-
$2.51
Significant Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) as of Q2 2023
23 filings reported holding NSPR - InspireMD, Inc. - Common Stock, $0.0001 par value as of Q2 2023.
InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.05M shares
of 42.1M outstanding shares and own 19.14% of the company stock.
Largest 10 shareholders include MARSHALL WACE, LLP (1.86M shares), Nantahala Capital Management, LLC (1.86M shares), ORBIMED ADVISORS LLC (1.86M shares), Soleus Capital Management, L.P. (1.38M shares), Velan Capital Investment Management LP (904K shares), PURA VIDA INVESTMENTS, LLC (55.7K shares), HighTower Advisors, LLC (26.8K shares), NOTTINGHAM ADVISORS, INC. (25K shares), HOLLENCREST CAPITAL MANAGEMENT (20K shares), and RENAISSANCE TECHNOLOGIES LLC (14.2K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.